POSC225 Challenges Regarding Implementation of Performance-Based Managed Entry Agreements (MEAS) for Advanced Therapy Medicinal Products (ATMPS)

Abstract

Authors

Y Vutova A Dacheva G Slavchev S Djambazov

Full Text Cite This Article
Back to ISPOR Europe 2021 Abstracts: Emerging Frontiers and Opportunities
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×